Publications by authors named "Michelle L Dean"

Claim this Profile
T
The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.
Tejas Patil, Dexiang Gao, Alexander Watson, Mandy Sakamoto, Yunan Nie, Michelle L Dean

Lung Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes in KRAS-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study.
Samir H Barghout, Luna Jia Zhan, Starvroula Raptis, Faisal Al-Agha, Niki Esfahanian, Michelle Liane Dean

Lung Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for Mutation-Positive Patients Treated with First-Line Osimertinib.
Amanda Jane Williams Gibson, Michelle Liane Dean, Ishjot Litt, Adrian Box, Winson Y Cheung

Curr Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Prognostic Significance of PIK3CA Mutation and CNV Status and Phosphorylated AKT Expression in Patients With Cervical Cancer Treated With Primary Surgery.
Kevin Martell, John B McIntyre, Tasnima Abedin, Elizabeth N Kornaga, Angela M Y Chan, Michelle L Dean

Int J Gynecol Pathol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in Mutation-Positive NSCLC.
Amanda J W Gibson, Aliyah Pabani, Michelle L Dean, Guillermo Martos, Winson Y Cheung

JTO Clin Res Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expected Cost Savings From Low-Dose Computed Tomography Scan Screening for Lung Cancer in Alberta, Canada.
Nguyen Xuan Thanh, Truong-Minh Pham, Arianna Waye, Alain Tremblay, Huiming Yang, Michelle L Dean

JTO Clin Res Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort.
Amanda J W Gibson, Adrian Box, Winson Y Cheung, Michelle L Dean, Anifat A Elegbede

Curr Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada.
Anifat A Elegbede, Amanda J Gibson, Andrea S Fung, Winson Y Cheung, Michelle L Dean

JTO Clin Res Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4 expression in lung carcinogenesis: Evaluating gender-specific differences in survival outcomes based on CXCR4 expression in early stage non-small cell lung cancer patients.
Andrea S Fung, Karen Kopciuk, Michelle L Dean, Adrijana D'Silva, Shannon Otsuka

PLoS One· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Real-World Outcomes for Patients With -Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors.
Amanda J W Gibson, Adrian Box, Michelle L Dean, Anifat A Elegbede, Desiree Hao

JTO Clin Res Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.
Ryan T Lewinson, Daniel E Meyers, Isabelle A Vallerand, Aleksi Suo, Michelle L Dean

J Am Acad Dermatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer.
Kevin Martell, John B McIntyre, Elizabeth N Kornaga, Angela M Y Chan, Tien Phan, Michelle L Dean

Gynecol Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence and prognostic significance of estrogen receptor beta expression in non-small cell lung cancer.
Emeka K Enwere, Michelle L Dean, Haocheng Li, Adrijana D'Silva, D Gwyn Bebb

Transl Lung Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer.
Anifat A Elegbede, Amanda J Gibson, Hao Fu, Michelle L Dean, Doreen A Ezeife

Am J Clin Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Asian ethnicity on outcome in metastatic EGFR-mutant non-small cell lung cancer.
Amanda J W Gibson, Adrijana D'Silva, Anifat A Elegbede, Roxana A Tudor, Michelle L Dean

Asia Pac J Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microwave-promoted insertion of Group 10 metals into free base porphyrins and chlorins: scope and limitations.
Michelle L Dean, Jason R Schmink, Nicholas E Leadbeater, Christian Brückner

Dalton Trans· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis